CIO & Founder at Asterozoa Capital
Member since: Jun '26 · 17 Opinions
Dollar-cost average over a year if you're excited by the name. The valuation is at nosebleed levels. You can buy a tranche and closely watch the lock-up sales. His concern is where the funds to buy all these shares will come from, for both SpaceX and Anthropic. If the funds come out of cash, that's good for the market, but if it means selling other shares, that's not good. He expects it to come from net cash. Would you pay taxable gains to sell NVDA in order to buy SpaceX? A risk is a deluge of insider selling. Overall, he will avoid SPCX.
They are converting from a REIT into a diversified asset management business, like Blackstone. Cheap at 4x PE and pays an 11% dividend with 200% coverage. At 30% discount to book value. When they convert the PE should reach 8-9x. Shares will double in 1-2 years. Great balance sheet.
(Analysts’ price target is $13.44)